Nov 14, 2007 7:30am EST Merck Serono Exercises Option to Rigel's R763/AS703569 and Aurora Kinase Inhibitors in the Japanese Territory
Nov 09, 2007 11:40am EST Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
Oct 30, 2007 7:30am EDT Rigel Announces Presentations at Upcoming Investor and Partnering Conferences
Jul 12, 2007 7:30am EDT Rigel Announces Start of Phase 1 Combination Therapy Study of R763/AS703569 in Advanced Malignancies
